ENTPD1 and neoplasm: Inhibition of two ectoenzymes important for the metabolism of extracellular nucleotides, CD73 (ecto-5’nucleotidase) and CD39 (ectonucleoside triphosphate diphosphohydrolase-1), greatly improved antitumor immune responses, thereby slowing tumor growth [359,360].